Gujarat Themis Biosyn Limited (GUJTHEM.BO)
INR 241.7
(-2.32%)
INR 241.7
(-2.32%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 853.97 Million INR | -6.29% |
| 2022 | 802.41 Million INR | 34.14% |
| 2021 | 598.21 Million INR | 43.57% |
| 2020 | 416.65 Million INR | 29.6% |
| 2019 | 321.49 Million INR | 414.33% |
| 2018 | 62.5 Million INR | 16.53% |
| 2017 | 53.64 Million INR | 8.18% |
| 2016 | 49.58 Million INR | 1.03% |
| 2015 | 49.08 Million INR | -5.78% |
| 2014 | 52.09 Million INR | 2.94% |
| 2013 | 50.6 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 203.47 Million INR | 1.71% |
| 2024 Q2 | 139.55 Million INR | -31.42% |
| 2023 Q3 | 167.67 Million INR | -1.0% |
| 2023 Q4 | 200.04 Million INR | 19.31% |
| 2023 FY | 751.97 Million INR | -6.29% |
| 2023 Q1 | 238.32 Million INR | 53.2% |
| 2023 Q2 | 169.36 Million INR | -28.94% |
| 2022 Q3 | 132.59 Million INR | -47.42% |
| 2022 Q2 | 252.19 Million INR | 6.72% |
| 2022 Q1 | 236.31 Million INR | 69.4% |
| 2022 FY | 802.41 Million INR | 34.14% |
| 2022 Q4 | 155.55 Million INR | 17.32% |
| 2021 Q2 | 178.69 Million INR | 10.42% |
| 2021 Q4 | 139.5 Million INR | 51.23% |
| 2021 Q1 | 161.82 Million INR | 112.02% |
| 2021 FY | 598.21 Million INR | 43.57% |
| 2021 Q3 | 92.24 Million INR | -48.38% |
| 2020 Q2 | 144.03 Million INR | 130.38% |
| 2020 Q1 | 62.52 Million INR | -51.54% |
| 2020 FY | 416.65 Million INR | 29.6% |
| 2020 Q4 | 76.32 Million INR | -25.96% |
| 2020 Q3 | 103.08 Million INR | -28.43% |
| 2019 Q2 | 16.37 Million INR | -21.9% |
| 2019 FY | 321.49 Million INR | 414.33% |
| 2019 Q4 | 129.01 Million INR | -11.64% |
| 2019 Q3 | 146.01 Million INR | 791.7% |
| 2019 Q1 | 20.96 Million INR | -22.74% |
| 2018 Q2 | 16.46 Million INR | -4.78% |
| 2018 Q1 | 17.28 Million INR | 40.69% |
| 2018 Q4 | 27.13 Million INR | 51.52% |
| 2018 FY | 62.5 Million INR | 16.53% |
| 2018 Q3 | 17.91 Million INR | 8.81% |
| 2017 FY | 53.64 Million INR | 8.18% |
| 2017 Q4 | 12.28 Million INR | -3.49% |
| 2017 Q1 | 11.48 Million INR | -13.62% |
| 2017 Q2 | 11.28 Million INR | -1.71% |
| 2017 Q3 | 12.73 Million INR | 12.81% |
| 2016 Q3 | 12.05 Million INR | 36.58% |
| 2016 Q4 | 13.29 Million INR | 10.22% |
| 2016 Q2 | 8.82 Million INR | -39.26% |
| 2016 Q1 | 14.53 Million INR | 4.51% |
| 2016 FY | 49.58 Million INR | 1.03% |
| 2015 Q1 | 12.25 Million INR | 44.8% |
| 2015 Q4 | 13.9 Million INR | 50.25% |
| 2015 Q3 | 9.25 Million INR | -14.82% |
| 2015 Q2 | 10.86 Million INR | -11.35% |
| 2015 FY | 49.08 Million INR | -5.78% |
| 2014 Q2 | 11.86 Million INR | -0.01% |
| 2014 Q1 | 11.86 Million INR | -12.06% |
| 2014 FY | 52.09 Million INR | 2.94% |
| 2014 Q4 | 8.46 Million INR | -38.38% |
| 2014 Q3 | 13.74 Million INR | 15.78% |
| 2013 Q1 | 8.47 Million INR | 799.0% |
| 2013 Q2 | 12.19 Million INR | 43.84% |
| 2013 FY | 50.6 Million INR | 0.0% |
| 2013 Q3 | 11.08 Million INR | -9.07% |
| 2013 Q4 | 13.49 Million INR | 21.7% |
| 2012 Q4 | -1.21 Million INR | -113.74% |
| 2012 Q1 | -1.4 Million INR | -103.13% |
| 2012 Q3 | 8.82 Million INR | 131.37% |
| 2012 Q2 | 3.81 Million INR | 371.22% |
| 2011 Q3 | -1.96 Million INR | 0.0% |
| 2011 Q4 | 44.92 Million INR | 2381.6% |
| 2008 Q4 | -6.16 Million INR | 0.0% |
| 2007 Q4 | -1.31 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 77.57 Million INR | -1000.896% |
| Cian Healthcare Limited | 53.96 Million INR | -1482.345% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | -5096.082% |
| Colinz Laboratories Limited | 14.64 Million INR | -5731.974% |
| Denis Chem Lab Limited | 142.87 Million INR | -497.7% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 7364.789% |
| Evoq Remedies Limited | 42.91 Million INR | -1889.832% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | -27.641% |
| MedPlus Health Services Limited | 1.31 Billion INR | 35.291% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 791.076% |
| PANJON LTD. | - INR | -Infinity% |
| PRAVEG LIMITED | 185.06 Million INR | -361.437% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | -1224.595% |
| Sastasundar Ventures Limited | -229.64 Million INR | 471.863% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 210438.916% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | -765.483% |
| BDH Industries Limited | 169.01 Million INR | -405.263% |
| DECIPHER LABS LIMITED | 53.74 Million INR | -1489.088% |
| ANG Lifesciences India Limited | 12.8 Million INR | -6569.082% |
| Veerhealth Care Limited | 34.19 Million INR | -2397.59% |
| Zenith Healthcare Limited | 196 Thousand INR | -435602.041% |
| Zenlabs Ethica Limited | 89.27 Million INR | -856.546% |
| Zenotech Laboratories Limited | 242.37 Million INR | -252.335% |
| Crestchem Limited | 27.25 Million INR | -3033.179% |
| Norris Medicines Limited | 11.15 Million INR | -7554.057% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | -261.454% |
| Sunil Healthcare Limited | -19.98 Million INR | 4373.94% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | -95.504% |
| Bacil Pharma Limited | -1.89 Million INR | 45180.397% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | -134.444% |
| Patidar Buildcon Limited | -1.83 Million INR | 46612.854% |
| Phaarmasia Limited | - INR | -Infinity% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | -49.169% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | -295.95% |
| Trimurthi Limited | -6.14 Million INR | 14001.521% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 8516.044% |
| Vivanza Biosciences Limited | 14.83 Million INR | -5657.659% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -160482.174% |
| Anuh Pharma Limited | 682.19 Million INR | -25.18% |
| Beryl Drugs Limited | 14.73 Million INR | -5696.742% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 633.488% |
| Deccan Health Care Limited | 185.32 Million INR | -360.789% |
| Godavari Drugs Limited | -67.67 Million INR | 1361.953% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -9399.177% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -10617.57% |
| Kerala Ayurveda Limited | 48.04 Million INR | -1677.413% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 2361.769% |
| Lactose (India) Limited | 137.78 Million INR | -519.784% |
| Makers Laboratories Limited | -34.91 Million INR | 2546.222% |
| Medi-Caps Limited | -17.21 Million INR | 5062.092% |
| Mercury Laboratories Limited | 62.14 Million INR | -1274.101% |
| Parmax Pharma Limited | 3.75 Million INR | -22645.096% |
| Roopa Industries Limited | 48.05 Million INR | -1677.006% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | -2400.296% |
| Syschem (India) Limited | 504.91 Million INR | -69.132% |
| Vikram Thermo (India) Limited | 339.45 Million INR | -151.57% |
| Bharat Parenterals Limited | 733.49 Million INR | -16.426% |
| Trident Lifeline Limited | 72.21 Million INR | -1082.612% |
| Concord Drugs Limited | 24.87 Million INR | -3333.483% |
| Gennex Laboratories Limited | 146.61 Million INR | -482.45% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 4866.289% |
| Vasundhara Rasayans Limited | 61.27 Million INR | -1293.655% |
| Parnax Lab Limited | 166.84 Million INR | -411.841% |
| Trinity League India Limited | 1.17 Million INR | -72702.728% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | -4886.721% |
| Tyche Industries Limited | 111.22 Million INR | -667.805% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | -70.554% |
| Transchem Limited | -17.43 Million INR | 4996.932% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 671.941% |
| Panchsheel Organics Limited | 288.28 Million INR | -196.221% |
| Coral Laboratories Limited | 142.63 Million INR | -498.723% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 34534.516% |
| Natural Capsules Limited | 112.4 Million INR | -659.765% |
| Auro Laboratories Limited | 95.77 Million INR | -791.648% |